X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Anti-MAP Kinase ERK1/ERK2 Rabbit pAb antibody

RRID:AB_2141135

Antibody ID

AB_2141135

Target Antigen

Mapk1 human, rat, mouse

Proper Citation

(Millipore Cat# 442704, RRID:AB_2141135)

Clonality

polyclonal antibody

Reference

PMID:28244869

Comments

seller recommendations: western blot, flow cytometry

Host Organism

rabbit

Vendor

Millipore

Cat Num

442704

Publications that use this research resource

YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κB.

  • Schimmack G
  • Elife
  • 2017 Feb 28

Literature context: ; ERK1/2 (RRID:AB_2141135, Calbioche


Abstract:

The ubiquitin ligase TRAF6 is a key regulator of canonical IκB kinase (IKK)/NF-κB signaling in response to interleukin-1 (IL-1) stimulation. Here, we identified the deubiquitinating enzyme YOD1 (OTUD2) as a novel interactor of TRAF6 in human cells. YOD1 binds to the C-terminal TRAF homology domain of TRAF6 that also serves as the interaction surface for the adaptor p62/Sequestosome-1, which is required for IL-1 signaling to NF-κB. We show that YOD1 competes with p62 for TRAF6 association and abolishes the sequestration of TRAF6 to cytosolic p62 aggregates by a non-catalytic mechanism. YOD1 associates with TRAF6 in unstimulated cells but is released upon IL-1β stimulation, thereby facilitating TRAF6 auto-ubiquitination as well as NEMO/IKKγ substrate ubiquitination. Further, IL-1 triggered IKK/NF-κB signaling and induction of target genes is decreased by YOD1 overexpression and augmented after YOD1 depletion. Hence, our data define that YOD1 antagonizes TRAF6/p62-dependent IL-1 signaling to NF-κB.